Cutaneous Leishmaniasis (CL) is one of the most prevalent clinical forms of leishmaniasis.
Preliminary data suggest that cytokine gene polymorphisms can contribute to resistance or …

Twelve unlinked microsatellite markers were used to determine the microsatellite profiles of
50 newly and 46 previously typed strains of L. tropica from various Israeli and Palestinian …

Background Leishmania donovani is the etiological agent of visceral leishmaniasis (VL) in
the Indian subcontinent. However, it is also known to cause cutaneous leishmaniasis (CL) in …

Background Among the neglected tropical diseases, leishmaniasis continues to be
prevalent in many tropical and subtropical countries despite international, national, and local …

American cutaneous leishmaniasis (ACL) is a vector-transmitted infectious disease with an
estimated 1.5 million new cases per year. In Brazil, ACL represents a significant public …

The genus Leishmania was first described in 1903 for the parasite Leishmania donovani,
but many additional species have been described since then. Although recent hierarchical …

Leishmaniasis is a major health problem with 600k-1M new cases worldwide and 1 billion at
risk. It involves a wide range of clinical forms ranging from self-healing cutaneous lesions to …

Background: Zoonotic cutaneous leishmaniasis (ZCL) is a polymorphic disease which may
show various clinical manifestations. Although genetic variability of the parasite is suggested …

Background The vector-borne cutaneous leishmaniasis (CL) is endemic in several regions
of Pakistan mainly affecting poor populations. Host genetic factors, particularly SLC11A1 …

BACKGROUND: Zoonotic cutaneous leishmaniasis (ZCL) is a polymorphic disease that may
show various clinical manifestations. Although it is suggested that the genetic variability of …